Smarter Investing for a Better World

Edwards Lifesciences helped transform heart care through minimally invasive valve replacement technologies. After years of market leadership, the stock now trades far below historical valuation levels as investors worry about slowing growth. Yet Edwards still combines elite profitability, a powerful moat, and promising new growth drivers in structural heart disease. We analyze what’s in store for one of healthcare’s highest-quality compounders.

Visa sits at the center of the global shift toward digital commerce, AI-driven transactions, and the decline of cash. Despite strong growth prospects and rising profitability, the stock currently trades below its historical valuation averages. Massive share buybacks and extraordinary financial strength continue supporting long-term shareholder returns. Solid climate metrics and renewable energy commitments make Visa a compelling GoodStock.

AI is creating a global electricity boom, and GE Vernova sits at the center of it. The company dominates critical power infrastructure markets spanning gas turbines, grid equipment, and renewables. With a massive backlog, accelerating earnings growth, and strong climate metrics, GEV looks increasingly strategic.

First Solar just confirmed strong growth and reaffirmed guidance, but the real story is evolving. AI-driven electricity demand is accelerating solar build-outs across the US. With a ~48GW backlog and attractive valuation, FSLR offers rare visibility and upside.

Many investors want portfolios that deliver strong long-term returns while remaining aligned with their values. This case study explores how socially conscious investors use Ziggma’s Portfolio Checkup and Optimizer to improve diversification, portfolio quality, risk management, and real-world impact alignment. Rather than relying on ESG labels alone, investors gain deeper visibility into what their portfolio actually supports. The result is a more intentional, resilient, and better-understood portfolio.

ESG and impact investing are not the same thing — and the difference matters more than most investors realize. One measures risk. The other measures results. Using a striking real-world example, this article unpacks why high ESG scores don't signal genuine impact, and what a portfolio built around real-world outcomes actually looks like.

A reverse stock split may make a struggling stock look more expensive — but it doesn’t fix the underlying business. While a few companies recover after one, most use it as a last resort, making careful analysis essential before seeing opportunity where there may only be risk.

TJX built its success by solving one of fashion’s biggest problems: excess inventory. Up to 30% of clothing goes unsold, creating massive inefficiency. TJX turns that waste into value while delivering steady growth and strong returns.

The market prices Accenture (ACN 🔎) at a record low valuation. At the same time, bookings are at record highs. Is this a major opportunity or a value trap?

A negative P/E ratio can look like an instant red flag — but is it really a reason to walk away? Understanding why a company has negative earnings can reveal whether you’re seeing a warning sign or a misunderstood opportunity hiding behind the numbers.

Agilent Technologies is a hidden force behind modern healthcare, diagnostics, and food safety. After a period of slowed growth, earnings are set to re-accelerate with projected 30.6% growth next year. At the same time, valuation has reset to more attractive levels, creating a compelling entry point. This is a high-quality compounder with real-world impact and renewed upside.

Colgate-Palmolive may not grab headlines, but its fundamentals are strengthening. With projected earnings growth of 47.6% and pricing power intact, the setup is improving. Its focus on efficiency and sustainability supports both margins and brand strength. A quiet compounder with credible upside.

Up 16% since our initial post, the world’s largest renewable company is now a top-tier AI infrastructure play. Here is why the 'GoodStocks' flywheel is just starting to spin.

Your portfolio may be generating returns—but do you know what’s driving them? Investing with values isn’t about sacrificing performance. It’s about understanding what your money supports—and gaining the clarity to align both.

Deckers is a standout example of responsible growth investing in action. With strong brand power, high profitability, and double-digit growth, it continues to compound value. Sustainability and employee satisfaction reinforce its competitive edge. At current valuation levels, the market may be underestimating its long-term potential.

What if investing for positive impact didn’t just align with your values — but actually boosted your returns? New research from Oxford and Schroders shows that impact-aligned equity portfolios can deliver superior risk-adjusted performance, proving that doing good and doing well don’t have to be trade-offs.

Boston Scientific is quietly becoming one of the most compelling growth stories in medical technology. Its devices treat life threatening diseases while delivering powerful financial performance. With strong revenue growth, expanding margins, and major innovation in cardiac care, the company combines profit with purpose. After a recent sell off, the stock may offer attractive long term upside.

Ralph Lauren is blending brand power with improving profitability and credible sustainability progress. Earnings are accelerating, margins are expanding, and climate and labor metrics are moving in the right direction. With a Ziggma Score of 79 and Impact Score of 71, RL stands out in global apparel. Here is why the stock could continue compounding for patient investors.